Valeant's creditors are not having it

Valeant’s creditors are not warming to the pharmaceutical giant’s plan to extend the deadline on filing its annual report, according to Bloomberg.

To recap, Valeant fell into a technical default when it failed to file its 10-K by March 15.

Valeant is offering creditors a fee and a boost in the interest rate on the debt in exchange for waiving the default and an amendment to its credit agreement.

Creditors have until Wednesday to tell the company whether or not they will accept the new terms for the company’s $11 billion of secured loans.

Valeant needs at least half of the investors holding the secured loans to agree to the new package for the amendment to go ahead. Some of those investors are pushing back.

From Bloomberg:

Those that are balking are demanding a higher interest rate and a better fee, said the people, who asked not to be identified because the discussions are private. They also want to impose some restrictions on the terms the company is offering on the proposal, they said.

Valeant’s stock started crashing in October, after allegations of malfeasance from a short seller combined with government scrutiny over its pricing practices sent investors runing for the exits.

Now the stock, which was once wildly popular on Wall Street is now down 86% from where it was this time last year.

For more on this head to Bloomberg>

NOW WATCH: The real estate trick billionaires use to sell their penthouses faster and for more money

NOW WATCH: Money & Markets videos

Want to read a more in-depth view on the trends influencing Australian business and the global economy? BI / Research is designed to help executives and industry leaders understand the major challenges and opportunities for industry, technology, strategy and the economy in the future. Sign up for free at research.businessinsider.com.au.